← Eichor
Study identifier: NCT04717869 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty

Condition: Frailty · Sarcopenia  ·  Sponsor: University of California, Los Angeles

PhaseN/A
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Scovotti, MA  ·  3102064484  ·  jscovotti@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative MedicineLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04717869